CIK 0001611747 · Non-accelerated filer
Scinai Immunotherapeutics Ltd.
Sign in to watch- Ticker
- SCNI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972-8-9302529
- Business address
- JERUSALEM BIOPARK, 2ND FLOOR, HADASSAH EIN KEREM CAMPUS, JERUSALEM, Israel, 00000
- Former names
- BiondVax Pharmaceuticals Ltd.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- S-8 Other Securities Offered to Employees in Benefit Plans
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- F-1 Offering Registration Statement for Certain Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- EFFECT Other Notice of Effectiveness
Page 3 of 25 · 498 filings